Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
| Datum | Name des Inhabers | Gehandelte Aktien | Wertspanne ($) | Transaktionstyp | Preisspanne ($) | Aktien am Meldungsende | % Veränderung |
|---|---|---|---|---|---|---|---|
| 2026-06-10 | Ms. Sylvia CheungCFO | 5,20k | 74,62k | Kauf | 14,35 | 79,01k | 7,05% |
| 2026-06-09 | Dr. Riad SherifCEO & Director | 4,67k | 64,25k | Kauf | 13,76 | 1,29M | 0,36% |
| 2026-05-25 | Dr. Arshad M. KhananiChair of Retina Scientific Advisory Board & Independent Director | 625,00 | 499,03k | Derivative Exercise and Retained Stock | 798,45 | 8,90k | 7,55% |
| 2025-03-13 | Ms. Christina M. AckermannIndependent Director | 1,86k | 56,58k | Kauf | 30,45 | 5,12k | 56,92% |
| 2026-03-09 | Dr. Riad SherifCEO & Director | -25,00k | 867,65k | Verkauf | 33,06 - 36,24 | 1,29M | -1,91% |
| 2026-02-25 | Dr. Arshad M. KhananiChair of Retina Scientific Advisory Board & Independent Director | 625,00 | 0,00 | Derivative Exercise and Retained Stock | - | 8,28k | 8,17% |
| 2026-02-13 | Mr. Anthony A. RosenbergIndependent Chairman | -5,07k | 0,00 | Other Disposition | - | 118,99k | -4,09% |
| 2026-02-13 | Ms. Sylvia CheungCFO | -3,51k | 0,00 | Other Disposition | - | 73,81k | -4,53% |
| 2026-02-13 | Dr. Riad SherifCEO & Director | -46,07k | 0,00 | Other Disposition | - | 1,03M | -4,27% |
| 2026-02-13 | Mr. Páll Ragnar JóhannessonChief Business Officer | -13,07k | 0,00 | Other Disposition | - | 255,76k | -4,86% |
| 2026-01-05 | Dr. Riad SherifCEO & Director | 12,30k | 0,00 | Derivative Exercise and Retained Stock | - | 1,08M | 1,15% |
| 2025-12-04 | Mr. Anthony A. RosenbergIndependent Chairman | 3,26k | 0,00 | Derivative Exercise and Retained Stock | - | 124,06k | 2,70% |
| 2025-12-04 | Ms. Christina M. AckermannIndependent Director | 3,26k | 0,00 | Derivative Exercise and Retained Stock | - | 3,26k | - |
| 2025-12-04 | Mr. Robert K. WarnerIndependent Director | 3,26k | 0,00 | Derivative Exercise and Retained Stock | - | 6,53k | 100,00% |
| 2025-12-04 | Dr. Arshad M. KhananiChair of Retina Scientific Advisory Board & Independent Director | 3,26k | 0,00 | Derivative Exercise and Retained Stock | - | 7,65k | 74,42% |
| 2025-11-29 | Dr. Arshad M. KhananiChair of Retina Scientific Advisory Board & Independent Director | 1,89k | 0,00 | Derivative Exercise and Retained Stock | - | 4,39k | 75,44% |
| 2025-11-13 | Mr. Lionel CarnotIndependent Director | 15,00k | 289,18k | Kauf | 19,28 | 32,50k | 85,71% |
| 2025-10-09 | Ms. Christina M. AckermannIndependent Director | -7,46k | 156,75k | Verkauf | 21,01 | 0,00 | -100,00% |
| 2025-10-05 | Dr. Riad SherifCEO & Director | 12,30k | 0,00 | Derivative Exercise and Retained Stock | - | 1,07M | 1,17% |
| 2025-09-23 | Dr. Riad SherifCEO & Director | -25,00 | 450,00 | Verkauf | 18,00 | 1,05M | -0,00% |
| 2025-09-04 | Mr. Anthony A. RosenbergIndependent Chairman | 3,26k | 0,00 | Derivative Exercise and Retained Stock | - | 120,80k | 2,78% |
| 2025-09-04 | Ms. Christina M. AckermannIndependent Director | 3,26k | 0,00 | Derivative Exercise and Retained Stock | - | 3,26k | - |
| 2025-09-04 | Mr. Robert K. WarnerIndependent Director | 3,26k | 0,00 | Derivative Exercise and Retained Stock | - | 3,26k | - |
| 2025-09-04 | Dr. Arshad M. KhananiChair of Retina Scientific Advisory Board & Independent Director | 3,26k | 0,00 | Derivative Exercise and Retained Stock | - | 10,81k | 43,27% |
| 2025-08-29 | Dr. Arshad M. KhananiChair of Retina Scientific Advisory Board & Independent Director | 1,89k | 0,00 | Derivative Exercise and Retained Stock | - | 7,54k | 33,33% |
| 2025-07-05 | Dr. Riad SherifCEO & Director | 12,30k | 0,00 | Derivative Exercise and Retained Stock | - | 1,05M | 1,18% |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
